The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Update with Hemispherx Biopharma, Inc. - Specialty Pharmaceutical Company Discusses Clinical Development and Competitive Advantage

SNNLive caught up with Thomas Equels, CEO of Hemispherx Biopharma, Inc. (NYSE American: HEB) at the Planet MicroCap Showcase 2019 in Las Vegas, NV.

Share With

Tuesday, July 02, 2019

   

© 2019 Stock News Now